Search clinical trials for: BMP-2

Total 18488 results

Daewoong Pharmaceutical Co. LTD.
Bio-alpha Co. LTD.

Completed

Efficacy and Safety of Bongros-BMP Compared to Bio-oss for Regeneration of Alveolar Bone Tissue After Maxillary Sinus Floor Augmentation

Regeneration of Alveolar Tissue After Maxillary Sinus Floor Augmentation

Korea, Republic of
University of Alabama at Birmingham
Medtronic; The Children's Tumor Foundation

Terminated

A Study of INFUSE Bone Graft (BMP-2) in the Treatment of Tibial Pseudarthrosis in Neurofibromatosis Type 1 (NF1) (NF107-BMP2)

NF1 | Congenital Pseudarthrosis of Tibia

United States, Australia
Assiut University

Not yet recruiting

Role of Novel Biomarkers Associated With In-stent Restenosis After Percutaneous Coronary Intervention

In-stent Restenosis
Indonesia University

Unknown

The Combined Effect of Mesenchymal Stem Cell, HA-CaSO4,BMP-2, and Implant in Inducing The Healing of Critical-Sized Bone Defect

Union

Indonesia
Ross Leighton
Canadian Orthopaedic Trauma Society

Withdrawn

A Randomized Controlled Cost Study of Infuse BMP 2 vs Iliac Crest Autograft for Non Union of Long Bone Fractures (Infuse)

Non Union Diaphyseal Fractures

Canada
Bristol-Myers Squibb

Completed

A Phase I Study of BMS-641988 in Japanese Patients With Castration Resistant Prostate Cancer

Prostate Cancer

Japan
SVS Institute of Dental Sciences

Completed

RhBMP-2 in Intrabony Defects - A Randomized Controlled Trial

Periodontitis

India
University of Bologna

Unknown

Colon Cleansing Efficacy With 1L vs. 2L vs. 4L-PEG for Colonoscopy Among Inpatients (INTERPRET)

Colon Disease

Italy
National Institutes of Health Clinical Center (CC)

Completed

Peptide Vaccine to Prevent Recurrence of Nasopharyngeal Cancer

Nasopharyngeal Neoplasms

United States
NYU Langone Health

Active, not recruiting

BMAC & Allograft vs BMP-2

Spinal Fusion

United States
R-Pharm

Completed

A Randomized Phase 2 Study of Ixabepilone Plus Carboplatin and Paclitaxel Plus Carboplatin in Advanced Nonsmall-Cell Lung Cancer

Advanced/Metastatic Non-Small Cell Lung Cancer

Germany, Korea, Republic of, Russian Federation, Taiwan, Australia, Italy, France, United States, Argentina, Spain
Bristol-Myers Squibb

Completed

To Evaluate The Relationship Between Plasma Drug Levels And Receptor Binding in Lung Using PET (Positron Emission Tomography) In Healthy Volunteers

Immunology

United States
BioMarin Pharmaceutical

Active, not recruiting

A Gene Therapy Study of BMN 331 in Subjects With Hereditary Angioedema (HAErmony-1)

Hereditary Angioedema | HAE

Spain, United States, Australia
Medtronic Spinal and Biologics

Completed

Pilot Study of rhBMP-2/BCP in Patients With Spinal Degeneration With Instability Requiring Surgical Fusion

Degenerative Disc Disease
University Hospital, Antwerp
FLUIDDA nv; Artesis University College, Antwerp

Unknown

Effects of IPV Assessed With Functional Imaging (IPV)

Chronic Obstructive Pulmonary Disease

Belgium
Bristol-Myers Squibb

Completed

Pharmacokinetics (Drug Levels in Blood) of BMS-986165 When Taken as Various Solid Tablet Prototypes by Healthy Participants

Healthy Participants

United States
University of Alberta
BioMimetix Pharmaceutical, Inc.

Completed

Islet Isolation Using MnTE-2-PyP (BMX-010) - Pilot Study

Type 1 Diabetes

Canada
BioAlpha Inc.

Completed

Clinical Study of Injectable Ceramics Bone Graft Substitute Containing rhBMP-2 (rhBMP-2)

Bone Graft | Alveolar Bone Preservation
Bristol-Myers Squibb

Completed

A Study to Compare the Taste and Levels in Blood Plasma of BMS-986165 When Taken as Different Formulations by Healthy Adult Participants

Healthy Participants

United States
BioAlpha Inc.

Unknown

A Multi-center, Comparative Clinical Trial to Evaluate the Efficacy and Safety of Inject BMP in Patients Undergoing Transforaminal Lumbar Interbody Fusion

Transforaminal Lumbar Interbody Fusion
Medtronic Spinal and Biologics

Completed

Pilot Study of rhBMP/BCP With or Without the TSRH® Spinal System for Posterolateral Lumbar Fusion in Patients With Degenerative Disc Disease

Degenerative Disc Disease
National Cancer Institute (NCI)

Completed

BMS-214662 Plus Trastuzumab in Treating Patients With Advanced Solid Tumors

Unspecified Adult Solid Tumor, Protocol Specific

United States
Medtronic Spinal and Biologics

Completed

Clinical Study of rhBMP-2/BCP With the TSRH® Spinal System for Posterolateral Lumbar Fusion in Patients With Degenerative Disc Disease

Degenerative Disc Disease
Vistakon Pharmaceuticals

Completed

Safety and Efficacy Study of a Eye Drop for Eye Allergy

Allergic Conjunctivitis

United States
Charite University, Berlin, Germany

Recruiting

Hypothermic Oxygenated (HOPE) Versus Normothermic Machine Perfusion (NMP) in Human Liver Transplantation (HOPE-NMP)

Liver Transplant Disorder | Hepatocellular Injury

Germany
Bristol-Myers Squibb

Completed

UNITY 2: A Study of an Investigational Treatment Regimen of DCV+ASV+BMS-791325 in a Fixed Dose Combination (the DCV 3DAA (Direct Acting Antiviral) Regimen) With or Without RBV for 12 Weeks for the Treatment of Chronic Hepatitis C Virus(HCV)Genotype 1 Infection in Subjects With Compensated Cirrhosis

Hepatitis C

United States, Australia, Canada, France
Pfizer

Terminated

Study Evaluating Safety Of BMP-655/ACS As An Adjuvant Therapy For Rotator Cuff Repair

Rotator Cuff Tear

Germany, Netherlands
Mylan Inc.
Mylan GmbH

Completed

Adalimumab PK Bioequivalence Study to EU and US Sourced Humira

Healthy Volunteers

Belgium
Chiesi Farmaceutici S.p.A.

Completed

Efficacy of CHF1535 Via NEXT DPI Versus pMDI and BDP DPI100µg on PeakExpiratoryFlow in Asthmatic Patients (Neptune)

Asthma

Poland
Bristol-Myers Squibb
European Organisation for Research and Treatment of Cancer - EORTC

Terminated

Study of CCNU (Lomustine) Plus Dasatinib in Recurrent Glioblastoma (GBM)

Glioblastoma

Switzerland, Netherlands, Italy, France
Bristol-Myers Squibb

Withdrawn

An Immuno-Therapy Study of Experimental Medication BMS-986205 Given With Nivolumab With or Without Chemotherapy Compared to Chemotherapy in Participants With Previously Untreated Stage IV or Recurrent Non-Small Cell Lung Cancer

Non-Small Cell Lung Cancer | Lung Cancer

Italy, Korea, Republic of, Turkey, Canada, Spain, Australia, Mexico, Taiwan, France, Germany, Switzerland, Greece, Japan, Austria, United States, Brazil, Czechia
M.D. Anderson Cancer Center

Active, not recruiting

Etigilimab and Nivolumab for the Treatment of Platinum-Resistant Recurrent Clear Cell Ovarian, Primary Peritoneal, or Fallopian Tube Cancer

Recurrent Platinum-Resistant Ovarian Carcinoma | Recurrent Fallopian Tube Clear Cell Adenocarcinoma | Recurrent Ovarian Clear Cell Adenocarcinoma | Recurrent Platinum-Resistant Fallopian Tube Carcinoma | Recurrent Platinum-Resistant Primary Peritoneal Carcinoma | Recurrent Primary Peritoneal...

United States
Bristol-Myers Squibb

Completed

Multiple Dose Study In Cancer Patients: Safety and Tolerability of BMS-754807 in Combination With Paclitaxel and Carboplatin in Patients With Advanced or Metastatic Solid Tumors

Advanced Solid Tumors | Metastatic Solid Tumors

Korea, Republic of, Canada, Australia
R-Pharm

Terminated

Randomized Study Evaluating Ixabepilone Plus Capecitabine or Docetaxel Plus Capecitabine in Metastatic Breast Cancer (IXTEND)

Breast Neoplasms

United States
Bristol-Myers Squibb
Cardioxyl Pharmaceuticals, Inc

Completed

A Dose-Defining Study of CXL-1020 in Patients With Systolic Heart Failure

Heart Failure

United States
NYU Langone Health

Active, not recruiting

Nivolumab Combined With BMS-986253 in HCC Patients

Hepatocellular Carcinoma

United States
Pfizer

Terminated

A Safety Study Of BMP-655/ACS As An Adjuvant Therapy For Treatment Of Rotator Cuff Tears

Rotator Cuff Tear

Japan
Mansoura University

Unknown

Effect of Gastric Balloon in Morbid Obesity: Prospective Study

Morbid Obesity

Egypt
Bristol-Myers Squibb

Completed

A Study of Dasatinib in Chronic Phase Philadelphia Chromosome Positive Chronic Myeloid Leukemia

Myeloid Leukemia, Chronic

Japan
National Cancer Institute (NCI)
NRG Oncology

Completed

Ixabepilone in Treating Patients With Recurrent or Persistent Uterine Cancer

Recurrent Uterine Corpus Sarcoma | Uterine Carcinosarcoma

United States
Siemens Healthcare Diagnostics Inc

Terminated

Serial BNP Testing for Heart Failure Management (USE-BNP)

Heart Failure

United States, Canada
University Hospital, Ghent

Terminated

A Prospective Randomized Controlled Trial on the Use of Bone Morphogenetic 7 (BMP-7) (OP-1®) and Demineralized Bone Matrix in Tibial Non-union

Non-union Diaphysary Tibial Fractures

Belgium
Thomas Jefferson University
Bristol-Myers Squibb

Active, not recruiting

Nivolumab and BMS986205 in Treating Patients With Stage II-IV Squamous Cell Cancer of the Head and Neck

Larynx | Squamous Cell Carcinoma | Lip | Oral Cavity Squamous Cell Carcinoma | Pharynx

United States
Bristol-Myers Squibb

Active, not recruiting

A Study of BMS-986466 With Adagrasib With or Without Cetuximab in Participants With Kirsten Rat Sarcoma Virus Glycine 12 to Cysteine (KRAS G12C)-Mutant Solid Tumors

Advanced Solid Tumors

United States, France, Argentina, Australia, Belgium, Israel, Italy, Spain
Hospital for Special Surgery, New York

Completed

Intra-articular Autologous Bone Marrow Aspirate Injection for Knee Osteoarthritis

Osteoarthritis, Knee

United States
China National Center for Cardiovascular Diseases
Peking University People's Hospital; Beijing Chao Yang Hospital; Hebei Medical...

Unknown

A New Classification and Interventional Therapy for Coronary Artery Ectasia (NCIPCAE)

Coronary Artery Ectasia

China
IntegoGen, LLC

Withdrawn

Allogeneic Micronized Amniotic Membrane Product for the Treatment of Hidradenitis Suppurativa

Hidradenitis Suppurativa

United States
University of Nebraska
BioMimetix JV, LLC

Recruiting

Safety Study of BMX-001 (Radio-protector) in Patients With Newly Diagnosed Anal Cancer

Radiation Exposure | Anal Cancer, Squamous Cell Carcinoma

United States
Bristol-Myers Squibb

Completed

A Taste Assessment of BMS-986165 in Healthy Participants

Healthy Participants

United States
AstraZeneca
Bristol-Myers Squibb

Terminated

Renal Mechanism of Action/Splay vs. TmG (MOA)

Diabetes, NOS

United States

3

Subscribe